C
NAUT icon

Covestor’s Nautilus Biotechnolgy NAUT Stock Holding History

Covestor’s Portfolio NAUT Stock Details NAUT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$0 Hold
8
– – ﹤0.01% 2596
2025
Q4 		$0 Hold
8
– – ﹤0.01% 2571
2025
Q3 		$0 Hold
8
– – ﹤0.01% 2584
2025
Q2 		$0 Hold
8
– – ﹤0.01% 2552
2025
Q1 		$0 Hold
8
– – ﹤0.01% 2545
2024
Q4 		$0 Buy
8
+1
+14% +$2 ﹤0.01% 2554
2024
Q3 		$0 Hold
7
– – ﹤0.01% 2549
2024
Q2 		$0 Hold
7
– – ﹤0.01% 2564
2024
Q1 		$0 Hold
7
– – ﹤0.01% 2557
2023
Q4 		$0 Buy
7
+2
+40% +$6 ﹤0.01% 2501
2023
Q3 		$0 Hold
5
– – ﹤0.01% 2484
2023
Q2 		$0 Buy
+5
New +$14 ﹤0.01% 2461

Other funds holding NAUT

ACM
AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
CM
Cercano Management Bellevue, Washington $2.32B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CA
Clearstead Advisors Cleveland, Ohio $10.9B AUM 18.41% 1-Year Est. Return
CFM
Comprehensive Financial Management Los Gatos, California $3.01B AUM 2.93% 1-Year Est. Return
ACI
Amazon.com Inc Seattle, Washington $2.63B AUM 20.53% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ST
Sentinel Trust Houston, Texas $1.13B AUM 24.31% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Covestor's NAUT Position: Q1 2026 in Review

Covestor held its Nautilus Biotechnolgy (NAUT) position steady in Q1 2026 at 8 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #2596.

Covestor first reported a position in NAUT in Q2 2023 and has held it in 12 quarters since. 81 funds tracked by Wall St. Rank hold NAUT as of Q1 2026.

  • Covestor held 8 shares of Nautilus Biotechnolgy worth $0 as of Q1 2026.
  • Covestor left its Nautilus Biotechnolgy share count unchanged in Q1 2026.
  • Nautilus Biotechnolgy made up ﹤0.01% of Covestor's portfolio in Q1 2026, its #2596 holding.
  • Covestor first reported a position in Nautilus Biotechnolgy in Q2 2023 and has held it in 12 quarters since.
  • 81 funds tracked by Wall St. Rank held Nautilus Biotechnolgy as of Q1 2026.

Based on Covestor's 13F filing for Q1 2026, filed 5 May 2026.